Here, we found a co-localization between the CYP1B1 and CD133 marker in RCC biopsies of cisplatin-treated patients, confirming the hypothesis of a potential renoprotective role of this enzyme during chemotherapy. Here, CYP1B1 is linked to renal cell carcinoma.